Thank you for standing by, and welcome to the AlloVir, Inc. meeting. I will now turn the call over to Vikas Sinha. Please go ahead. Good morning. The meeting will come to order. The business before this meeting is described in our Notice of Special Meeting of Stockholders and Proxy Statement, a copy of which has been mailed to all our stockholders. This meeting is being held in accordance with the corporation's bylaws and Delaware law. A copy of the agenda and rules of conduct for the meeting has been provided through the web portal. It is our intention to conduct this meeting in accordance with these documents. There will be an opportunity for questions about all of the proposals prior to the voting. Please adhere to the rules of conduct in addressing this meeting in connection with the proposals. If you have sent in a proxy, your vote will be counted automatically without any further action on your part. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, please click on the Vote Here link on the web portal and follow the instructions. The stockholders' list shows that holders of 115,566,991 shares of common stock of the company are entitled to vote at this meeting. I have been advised by the Inspector of Election that a quorum is present at this meeting, so I declare the meeting duly and lawfully convened. Approval of an amendment to the Third Amended and Restated Certificate of Incorporation to effect a reverse stock split. The first item of business stated in the Notice of Special Meeting of Stockholders is a vote to approve an amendment to AlloVir's Certificate of Incorporation to, at the discretion of the Board of Directors of AlloVir, effect a reverse stock split of AlloVir's issued common stock at any time prior to January 10, 2026, at a ratio in the range between 1:15 and 1:35 inclusive, with the final ratio and effectiveness of all other ratios of such amendment and the abandonment of such amendment to be determined at the discretion of the Board without further approval of all authorization of AlloVir's stockholders. The reverse stock split proposal is included in a public announcement. Adjournment proposal. The next order of business is to approve an adjournment of AlloVir's special meeting if necessary to solicit additional proxies if there are not sufficient votes in favor of the reverse stock split proposal. A vote of the adjournment proposal will only be taken if there are not sufficient votes to approve the reverse stock split proposal. We will now open the floor to questions concerning the matters to be voted upon. If you would like to ask a question, please enter them through the Ask a Question box located on the meeting website. There are no questions. Okay. It is now 9:03 A.M. Eastern Time on January 9, 2025, and the polls for each matter to be voted on at this special meeting are now open. Stockholders who are voting via the web portal, please submit your vote now. You must submit your votes via the web portal now in order for them to be counted. The Inspector of Election will not accept proxies or votes or any changes or revocations submitted after the closing of the polls. Pursuant to the standard procedures, the Inspector of Election will tabulate the votes in accordance with such procedures. The results of the balloting will be certified by the Inspector of Election. Upon certification, the company will publicly announce the results of the voting on items presented at this meeting. It is now 9:05 A.M. Eastern Time on January 9, 2025. The polls are now closed. Following tabulation of voting by the Inspector of Election, the preliminary voting results will be available after the meeting. The final numbers of votes cast will be filed on EDGAR and made available on our website. This concludes the formal agenda items. Since there are no other matters to come before the meeting, this meeting shall now be adjourned. Thank you for your attendance. This concludes today's meeting. You may now disconnect.